Skip to content
Contact
About PORTAL
Our Team
Our Work
Innovation Incentives and Competition
Regulation and Clinical Evidence
Price, Value, and Access
Search Our Library
Implications of Medicare Negotiation and Most-Favored-Nation Pricing for Cancer Medicine Costs
HOME
/
Research Publications
/
Implications of Medicare Negotiation and Most-Favored-Nation Pricing for Cancer Medicine Costs